All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Less invasive HeartMate 3 left ventricular assist device implantation

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F18%3A00076945" target="_blank" >RIV/00023001:_____/18:00076945 - isvavai.cz</a>

  • Result on the web

    <a href="http://jtd.amegroups.com/article/view/19930/html" target="_blank" >http://jtd.amegroups.com/article/view/19930/html</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.21037/jtd.2018.01.26" target="_blank" >10.21037/jtd.2018.01.26</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Less invasive HeartMate 3 left ventricular assist device implantation

  • Original language description

    Background: The novel HeartMate 3 (Abbott, Chicago, IL, USA) left ventricular assist device (LVAD) was worldwide first implanted by Prof. Schmitto and his team in 2014 at the Hannover Medical School, Germany and received CE Mark approval in October, 2015 following completion of a clinical trial. Methods: Although HeartMate 3 implantation in the clinical trial was restricted to conventional sternotomy, the small size of the pump allows for less-invasive implantation, generally associated with less trauma and reduced perioperative complication rates. Herein we describe our first experiences with a less-invasive implantation of the HeartMate 3 using an upper hemi-sternotomy combined with anterior lateral thoracotomy approach. Results: Results demonstrate the feasibility of this novel, less invasive technique for HeartMate 3 LVAD implantation with diminished surgical trauma, less postoperative bleeding, maintenance of the chest stability, reduced need of blood product transfusion and earlier recovery. Conclusions: The results of our study indicate that less-invasive implantation of the HeartMate 3 is technically feasible and offers several benefits for surgical outcome and may become the standard of care for LVAD implantation techniques.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of thoracic disease

  • ISSN

    2072-1439

  • e-ISSN

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    Supplement 15

  • Country of publishing house

    CN - CHINA

  • Number of pages

    4

  • Pages from-to

    "S1692"-"S1695"

  • UT code for WoS article

    000435843200002

  • EID of the result in the Scopus database

    2-s2.0-85048870276